Tech Company Financing Transactions

Xanthus Pharmaceuticals Funding Round

Xanthus Pharmaceuticals, based in Cambridge, secured $10 million from HealthCare Ventures, Oxford Bioscience Partners and Still River Funds.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

300 Technology Square 5th Floor
Cambridge, MA 02139
USA

Phone

(617) 225-0522

Website

www.xanthus.com

Email Address

[email protected]

Overview

Xanthus is a biopharmaceutical company focused on the discovery, development, acquisition and commercialization of small-molecule therapeutics for the treatment of cancer and autoimmune disorders.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Richard Dean

        

Chief Financial Officer

Robert Boisjoli

        

Chief Medical Officer

Robert Capizzi

        

Chief Operating Officer

Michael Boss

        

Chief Scientific Officer

Alfred Ajami

        

Vice President

John Lister-James

        

VP - Regulatory Affairs

Kris Piper

        

Browse more venture capital transactions:

Prev: 3/31/2006: Collective Intellect venture capital transaction
Next: 3/31/2006: Sigma Resources and Technologies venture capital transaction

Share this article

Where The Data Comes From

We document funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary